Medication info
Teravial Tablets 100 mg (Sitagliptin Hydrobromide Monohydrate)

Teravial Tablets 100 mg (Sitagliptin Hydrobromide Monohydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›113.4mg / 1 tablet
Manufacturer / importer
Teragen Etex Co., Ltd.
Appearance
Bright brown, round, bilaterally convex film-coated tablets
Packaging
28 tablets/PTP [(14 tablets/PTP x 2)]
Approval status
Active

MFDS item code 202101861 · Approved 2021.02.24 · Insurance code 698504760

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Administer 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dosage adjustment is required according to renal function, assessment of renal function is recommended before starting this medicine and periodically during treatment. 1. No dosage adjustment is required in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is required in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily in patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Ingredients

Manufacturer
Teragen Etex Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Difficulty in blood sugar control in patients with type 2 diabetes
View approved original text

This medicine is used as an adjunct to diet and exercise to improve blood sugar control in patients with type 2 diabetes. It can be administered as monotherapy for initial treatment, and in cases where blood sugar control is difficult with monotherapy and previous usage of anti-diabetic medications has not occurred, it is administered in combination with metformin. Additionally, when sufficient blood sugar control is not achieved with monotherapy of sulfonylureas, metformin, thiazolidinediones, or insulin, this medicine may be used in combination. The therapy effect can be enhanced by adding this medicine when controlling blood sugar is difficult even in combination with multiple medications. It is flexibly applied to improve blood sugar control in various scenarios.

How to take

Adult dose

Administer 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dosage adjustment is required according to renal function, assessment of renal function is recommended before starting this medicine and periodically during treatment. 1. No dosage adjustment is required in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is required in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily in patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Precautions

This medicine may cause serious allergic reactions in some patients; therefore, if symptoms such as rash, hives, difficulty breathing, or swelling of the face or neck occur after use, discontinue the medication immediately and consult a physician. During the use of this medicine, symptoms of pancreatitis, inflammation of the pancreas, may occur; rapid medical attention should be sought if abdominal pain, vomiting, or loss of appetite occurs. This medicine should not be used in patients with type 1 diabetes or diabetic ketoacidosis, nor in patients with an allergy to this medicine or its ingredients. Patients with reduced kidney function may experience delayed excretion of this medicine, so the dosage may need adjustment by a physician, and kidney status should be checked. In clinical trials, side effects such as upper respiratory tract infections, pharyngitis, headache, etc. were primarily reported, and caution is needed as hypoglycemic symptoms can occur when taking it in conjunction with other anti-diabetic medications. The risk of hypoglycemia may increase when this medicine is taken in conjunction with insulin or sulfonylureas, which can induce hypoglycemia, so blood sugar levels should be checked frequently, and dosage adjustments may be necessary. If severe joint pain or blistering symptoms occur during drug intake, consult a doctor immediately to decide whether to discontinue the medication. Pregnant or breastfeeding women should avoid taking this medicine as its safety has not been established. Elderly patients may have decreased kidney function, so it is important to conduct kidney function tests before use and adjust the dosage according to the doctor's instructions. In case of overdose, seek medical attention immediately for appropriate treatment, as this medicine can be partially removed through hemodialysis, which may be considered if necessary. This medicine tends to have fewer interactions with other medications, but certain drug interactions may lead to changes in blood concentration; hence, all currently taken medications should be disclosed to the physician.

Side effects

  • Anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • hypoglycemia
  • upper respiratory tract infection
  • nasopharyngitis
  • headache
  • diarrhea
  • abdominal pain
Show 29 more
  • nausea
  • constipation
  • vomiting
  • elevated liver enzymes
  • acute renal failure
  • severe and disabling arthralgia
  • bullous pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • dyspepsia
  • dizziness
  • increased ALT
  • increased AST
  • elevated blood triglycerides
  • gastritis
  • pneumonia
  • diabetes complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored in a tightly sealed container to prevent air or moisture ingress, preferably at a temperature between 1 and 30 degrees Celsius room temperature. Storing it this way helps maintain the efficacy and prevent degradation of the medicine.

Appearance and packaging

Appearance

Bright brown, round, bilaterally convex film-coated tablets

Package unit

28 tablets/PTP [(14 tablets/PTP x 2)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.